Systematic review with meta-analysis: recurrence of hepatocellular carcinoma following direct-acting antiviral therapy

Alimentary Pharmacology & Therapeutics
N SaraiyaAmit G Singal

Abstract

Although studies suggest decreased incident hepatocellular carcinoma (HCC) after direct-acting antivirals (DAA), data are conflicting regarding HCC recurrence and aggressiveness in patients who have a history of HCC with complete response. Characterize HCC recurrence patterns after DAA therapy. Two reviewers searched MEDLINE and SCOPUS from January 2015 to December 2017 and identified studies evaluating HCC recurrence patterns following DAA therapy. A pooled estimate was calculated using the DerSimonian and Laird method for a random effects model. The study was conducted in accordance with PRISMA guidelines. Among 24 studies (n = 1820 patients), the proportion of patients with HCC recurrence following DAA therapy ranged from 0% to 59% (pooled estimate 24.4%; 95% CI: 18.4%-30.4%). Among 11 full text manuscripts, pooled HCC recurrence was 21.9% (95% CI: 16.2%-28.3%). Factors associated with recurrence included history of prior HCC recurrence and a shorter interval between HCC complete response and DAA initiation. Nine studies comparing DAA-treated and interferon-treated or untreated patients found similar recurrence among DAA-treated patients. Most (77.8%) patients with HCC recurrence were detected at an early tumour stage, of wh...Continue Reading

References

Sep 6, 2003·BMJ : British Medical Journal·Julian P T HigginsDouglas G Altman
Jul 23, 2009·Annals of Internal Medicine·David MoherUNKNOWN PRISMA Group
Dec 2, 2009·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Amit G SingalPhilip S Schoenfeld
Dec 14, 2011·The American Journal of Gastroenterology·Shuichiro ShiinaKazuhiko Koike
Dec 21, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Srinevas K ReddyAllan Tsung
Jan 5, 2012·Journal of General Internal Medicine·Amit G SingalJasmin A Tiro
Feb 23, 2012·Digestive Diseases and Sciences·Amit G Singal, Jorge A Marrero
Apr 28, 2012·Gastroenterology·Hashem B El-Serag
May 17, 2013·The New England Journal of Medicine·T Jake Liang, Marc G Ghany
Jul 11, 2014·Annals of Surgery·Parissa TabrizianSasan Roayaie
Feb 2, 2016·Journal of Hepatology·Graham R FosterUNKNOWN HCV Research, UK
Jun 12, 2016·Journal of Hepatology·UNKNOWN ANRS collaborative study group on hepatocellular carcinoma (ANRS CO22 HEPATHER, CO12 CirVir and CO23 CUPILT cohorts). Electr
Jul 16, 2016·Journal of Hepatology·Jean-Charles Nault, Massimo Colombo
Jan 5, 2017·Liver International : Official Journal of the International Association for the Study of the Liver·María ReigJordi Bruix
Feb 14, 2017·Journal of Hepatology·Giuseppe CabibboUNKNOWN Italian Liver Cancer (ITA.LI.CA) group
Apr 8, 2017·Seminars in Liver Disease·María ReigJordi Bruix
Apr 20, 2017·Liver International : Official Journal of the International Association for the Study of the Liver·Victor VirlogeuxFabien Zoulim
Jun 20, 2017·Journal of Hepatology·Hiroko NagataUNKNOWN Ochanomizu Liver Conference Study Group
Jun 24, 2017·Gastroenterology·Fasiha KanwalHashem B El-Serag
Aug 10, 2017·Alimentary Pharmacology & Therapeutics·G CabibboUNKNOWN Rete Sicilia Selezione Terapia - HCV (RESIST-HCV)
Sep 1, 2017·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Lewis R RobertsKhaled Mohammed
Oct 13, 2017·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Neil Mehta, Francis Y Yao
Oct 13, 2017·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·James F Trotter
Oct 17, 2017·Alimentary Pharmacology & Therapeutics·E OgawaUNKNOWN Kyushu University Liver Disease Study (KULDS) Group

❮ Previous
Next ❯

Citations

Dec 22, 2017·Alimentary Pharmacology & Therapeutics·P S Tan, S G Lim
Jun 7, 2019·Clinical Liver Disease·Feng Su, George N Ioannou
Mar 30, 2019·Current Hepatology Reports·Feng Su, George N Ioannou
Oct 12, 2018·Viruses·Pierre PradatEric Trépo
Oct 22, 2019·Lancet·C Wendy SpearmanMark Sonderup
Dec 22, 2020·Liver International : Official Journal of the International Association for the Study of the Liver·Shu-Chi WangMing-Lung Yu
Dec 5, 2020·Journal of Hepatology·Francesco Negro
May 2, 2020·Journal of the Formosan Medical Association = Taiwan Yi Zhi·Ming-Lung YuWan-Long Chuang
Aug 12, 2020·HPB : the Official Journal of the International Hepato Pancreato Biliary Association·Michael K TurgeonMaria C Russell
Dec 16, 2020·Minerva medica·Stefano GittoPietro Andreone
Jul 31, 2021·World Journal of Gastroenterology : WJG·María B PisanoPamela Valva
Jan 8, 2019·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Elisabetta DegasperiPietro Lampertico
Aug 14, 2021·Clinical Liver Disease·Nicole E Rich, Amit G Singal
Aug 11, 2021·Journal of Gastroenterology and Hepatology·Eiichi OgawaUNKNOWN Kyushu University Liver Disease Study (KULDS) Group
Oct 9, 2021·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Jess HowellPaul Gow

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.